Has Hind Hamdan received payments from drug or device companies?

Yes. Drug and device makers reported $4,028 in general payments to Hind Hamdan across 194 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Hind Hamdan did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Hind Hamdan come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Hind Hamdan

Hematology & Oncology · Hagerstown, MDNPI 1316989098

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.7% of the total across 194 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 46 manufacturers, the largest accounting for just 8.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,384 and has fallen 61.8% since, to $910 in 2021.

$4,028in general payments, 2019–2025

Across 194 payments — averaging $20.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$350
Amgen$341
AstraZeneca$320
E.r. Squibb & Sons, L.L.C.$285
Genentech USA, Inc.$266
Boehringer Ingelheim$183
plus $2K from 40 others

$10,538in research payments, 2019–2025

Across 5 payments — averaging $2107.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Pfizer$11K

What the payments were for

Food & beverage$3,69692%
Education$3338%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson(2 entities)	20	$350
Amgen	13	$341
AstraZeneca(2 entities)	13	$320
E.r. Squibb & Sons, L.L.C.	18	$285
Genentech USA, Inc.	14	$266
Boehringer Ingelheim	3	$183
Pfizer	14	$173
Takeda Pharmaceuticals U.S.A., Inc.	4	$173
Merck	10	$145
Pharmacyclics LLC, An Abbvie Company	6	$116
Sanofi-aventis U.S. LLC	1	$100
Novartis	5	$100
AbbVie	4	$93
Lilly USA, LLC	5	$90
Array Biopharma Inc	4	$89
Bristol Myers Squibb	5	$88
GSK	3	$82
Daiichi Sankyo Inc.	3	$80
Incyte Corporation	4	$67
Gilead(2 entities)	3	$59
Sanofi	3	$58
EMD Serono, Inc.	2	$56
Exelixis Inc.	3	$53
Eisai Inc.	3	$51
ASD Specialty Healthcare, LLC	1	$46
Astellas Pharma US Inc	2	$45
Tersera Therapeutics LLC	2	$44
Epizyme, Inc.	2	$42
Bayer	2	$40
Deciphera Pharmaceuticals Inc.	2	$40
Taiho Oncology, Inc.	2	$35
Puma Biotechnology, Inc.	2	$35
Seagen Inc.	2	$33
Agios Pharmaceuticals, Inc.	2	$31
TG Therapeutics, Inc.	1	$25
Tesaro, Inc.	1	$24
Dendreon Pharmaceuticals LLC	1	$23
EUSA Pharma (US) LLC	1	$21
Acceleron Pharma, Inc.	1	$20
Myovant Sciences Inc.	1	$17
Regeneron Healthcare Solutions, Inc.	1	$16
AMAG Pharmaceuticals, Inc.	1	$16
Verastem, Inc.	1	$16
Lexicon Pharmaceuticals, Inc.	1	$15
Aurobindo Pharma USA, Inc.	1	$15
Acrotech Biopharma Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

GILOTRIF$125
LYNPARZA$125

How this compares

$4,028 in reported general payments places this provider in the 60th percentile of 242 hematology & oncology providers in Maryland.

See all hematology & oncology providers in Maryland →

Other hematology & oncology in Hagerstown

Alida EspinozaHagerstown$23K
Yong TangHagerstown$18K
Ralph BocciaBethesda$3.1M
Sandra SwainBethesda$1M
Kashif AliSilver Spring$987K
Ani BalmanoukianBaltimore$842K
Benjamin LevyBaltimore$578K
Patrick FordeBaltimore$269K
Noah HahnBaltimore$133K
Walid El AyassSalisbury$111K

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →